title: Re: Hypertension as a biomarker of efficacy in patients with metastatic renal cell carcinoma treated with sunitinib.
authors.forename: Anton H
authors.initials: AH
authors.lastname: van den Meiracker
authors.forename: A H Jan
authors.initials: AH
authors.lastname: Danser
authors.forename: Stefan
authors.initials: S
authors.lastname: Sleijfer
authors.forename: Mariette H W
authors.initials: MH
authors.lastname: Kappers
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D001794:Blood Pressure / Q000187:drug effects*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D006801:Humans; D006973:Hypertension / Q000139:chemically induced*; D007211:Indoles / Q000009:adverse effects*; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D011758:Pyrroles / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles